| APCS |
396921 |
local depletion by ionized agarose gel |
Accelerated wound healing |
| CALR |
100381266 |
Protein administration |
Accelerated wound healing; increase in epithelial migration and granulation tissue formation; marked proliferation of basal keratinocytes and dermal fibroblasts; dense cellularity of the dermis with notably increased numbers of macrophages and well-organized collagen fibril deposition |
| EGF |
397083 |
Protein administration |
Accelerated re-epithelialization |
| EGF |
397083 |
Protein administration |
Accelerated wound closure; improved wound healing quality in terms of number of arranged microvasculature, fibroblast migration and proliferation, collagen deposition and evolution of the inflammatory response |
| EGF |
397083 |
Overexpression (Adenoviral transfection) |
Promotion of resurfacing; enhanced wound maturity |
| ERBB3 |
100126862 |
Overexpression (Adenoviral transfection) |
Promotion of resurfacing; enhanced wound maturity |
| FGF2 |
397643 |
Protein administration |
Better reconstruction quality in terms of hardness and the function of the stratum corneum |
| GJA1 |
397259 |
Peptide administration |
Decreased scar progenitor tissue area; promoted restoration of dermal histoarchitecture and mechanical strength; reduction in inflammatory neutrophil infiltration |
| HSP90AA1 |
397028 |
Peptide administration |
Accelerated wound healing; accelerated re-epithelialization |
| LTF |
397649 |
Protein administration |
Accelerated re-epithelialization; increased keratinocyte proliferation and migration |
| NRG3 |
100158106 |
Overexpression (Adenoviral transfection) |
Promotion of resurfacing; enhanced wound maturity |
| VTN |
397192 |
Protein administration |
Accelerated re-epithelialization; improved morphological features such as wound contraction, scar profile, and hair follicle density |
